Thanks for joining us at EuroPCR 2018! Check below our key highlights in pictures!
Hakuehdot
Thanks for joining us at EuroPCR 2018! Check below our key highlights in pictures!
Hot topics of the week included the Late-breaking trial: two-year clinical outcome data from SYNTAX II and the health economic data which demonstrates that an iFR-guided strategy reduces costs and improves patient comfort compared to an FFR-guided strategy, while delivering consistent cost savings and patient outcomes.
On-site at EuroPCR Philips showcased its advanced interventional imaging systems, smart devices, planning and navigation software, and services, including:
Azurion, Philips’ next generation image-guided therapy platform, which enables clinicians to easily and confidently perform a range of routine and complex procedures, helping them to optimize interventional lab performance and provide superior care. A recent study demonstrated the significant clinical workflow and staff experience benefits of the platform.
iFR Roadmap [1] exclusive to Philips' interventional labs, enables physicians to navigate coronary arteries and corresponding iFR data in real time.
Philips’ SyncVision iFR co-registration solution, which couples iFR physiology measurement pull-back results to the coronary angio and can be utilized in the stenting process when lesions are more complex.
When it comes to health, people deserve the best. Yet despite advances, progress is too often slowed. By systems that can’t communicate. By data that gets locked in silos. By clinicians who can’t see the full picture fast enough and patients who feel lost in the system.
At Philips, we collaborate on designing innovations to seamlessly bring together people, data
We aim to deliver seamless cardiovascular care and improved workflows to reduce variation in the standard of care, and to find the optimal pathways for better clinical outcomes, lower
At EuroPCR you will be able to visit the Philips Azurion Experience at our booth F18 on level 1.
Health economic data from the DEFINE FLAIR trial demonstrates an
1. Davies JE, et al., DEFINE-FLAIR: A 2. Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow 3. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018. 4. An
Improving workflow in the interventional lab
Disclaimer: *
What's trending
Press inquiries:
For EuroPCR, Press Inquiries, please contact
Fabienne van der Feer
fabienne.van.der.feer@philips.com
Twitter: @FC_Feer
News
@PhilipsLiveFrom